Twin Tree Management, LP Beam Therapeutics Inc. Call Options Transaction History

Twin Tree Management, LP

  • $50 Billion
  • Q3 2024

Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2022

May 11, 2022
SELL
$53.73 - $82.16 $365,364 - $558,688
-6,800 Closed
0 $0
Q4 2021

Feb 10, 2022
BUY
$68.02 - $99.06 $462,536 - $673,608
6,800 New
6,800 $542,000
Q2 2021

Aug 12, 2021
SELL
$64.12 - $128.71 $1.36 Million - $2.73 Million
-21,200 Closed
0 $0
Q1 2021

May 17, 2021
BUY
$71.28 - $120.75 $1.51 Million - $2.56 Million
21,200 New
21,200 $1.7 Million

Others Institutions Holding BEAM

# of Institutions
236
Shares Held
75.2M
Call Options Held
438K
Put Options Held
232K
View Full List

About Beam Therapeutics Inc.

BEAM Quotes by TradingView
  • Ticker BEAM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 70,354,600
  • Market Cap $1.78B
  • Description
  • Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen ...
More about BEAM
Track This Portfolio

Track Twin Tree Management, LP Portfolio

Follow Twin Tree Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Twin Tree Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Twin Tree Management, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email